Updated:
CarelonRx
CarelonRx manages 360M+ prescriptions for 17M members as Elevance Health's captive PBM, driving negative specialty drug trends for nearly half its clients.
CarelonRx
CarelonRx is the pharmacy benefit management (PBM) subsidiary of Elevance Health, the insurer formerly known as Anthem, and traces its origin to the payer’s 35-year history of administering drug benefits. While Elevance Health does not disclose a launch date for the unified CarelonRx brand, the PBM consolidated Anthem’s legacy drug-management operations under a single entity to serve the parent’s affiliated health plans and external employer clients. The firm intervenes across the prescription value chain: formulary design, retail-network contracting, specialty pharmacy management, and home-delivery fulfillment. CarelonRx internal data for 2024 shows it managed over 360 million prescriptions, with 44% of its clients experiencing a negative specialty drug trend — a metric that captures their ability to offset rising high-cost drug spend through rebate negotiation and therapy management. Its platform spans commercial employer groups, Medicare, Medicaid, and health insurance marketplace plans. The firm’s digital infrastructure supports electronic prior authorization for providers and member-facing tools for drug pricing, refills, and pharmacy locators. CarelonRx operates from Morristown, New Jersey, and serves 17.2 million members. It sits alongside Elevance’s other Carelon-branded businesses — Carelon Health (care delivery) and Carelon Insights (data analytics) — forming a vertically integrated healthcare services stack that the parent markets to other payers and self-funded employers. In October 2025, a CarelonRx-authored study assessed GLP-1 receptor agonists using real-world data to quantify therapeutic benefits and risks, reflecting the PBM’s emphasis on evidence-based coverage policy. The firm’s structural differentiator is its captive patient volume. Unlike standalone PBMs that must bid for payer contracts, CarelonRx inherits a 17-million-member base from Elevance Health’s insurance operations, turning its formulary decisions into a population-level health intervention rather than a third-party negotiation exercise.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Morristown
Corporate office
Morristown, NJ, United States
Sector focus
Frequently asked questions
How does CarelonRx fit within Elevance Health's corporate structure?
CarelonRx is a wholly owned subsidiary of Elevance Health, formerly Anthem. It serves as the in-house pharmacy benefit manager for Elevance’s affiliated health plans while also offering PBM services to external employer groups. The Carelon brand encompasses additional Elevance subsidiaries — Carelon Health (care delivery) and Carelon Insights (data analytics) — creating a vertically integrated healthcare services portfolio.
What is CarelonRx's scale in terms of membership and prescription volume?
CarelonRx internal data for 2024 reports 17.2 million members and over 360 million prescriptions managed annually. The firm draws on 35 years of pharmacy benefit management experience inherited from its Anthem-era predecessor operations.
Does CarelonRx participate in specialty pharmacy management?
Yes. CarelonRx integrates specialty pharmacy into its core PBM service model, managing high-cost therapies through negotiated rebates and clinical oversight. The firm disclosed that 44% of its clients had a negative specialty drug trend in 2024, a metric that reflects their ability to offset rising specialty costs.
Who runs CarelonRx?
CarelonRx does not publicly disclose its leadership team on its primary website, and no named executives were identifiable from available sources as of 2026. The firm operates under the broader Carelon and Elevance Health executive structure, which is led by Elevance Health's CEO.
Does CarelonRx manage a home-delivery pharmacy?
Yes. CarelonRx offers home-delivery mail-order pharmacy services as part of its integrated PBM platform. This allows the firm to bypass retail pharmacies for maintenance medications, capturing additional margin and controlling fulfillment directly.
What investment mandate does CarelonRx hold, and how do external allocators interact with the entity?
CarelonRx is an operating pharmacy benefit manager, not an investment vehicle. It does not deploy third-party capital, manage a fund, or hold a publicly reported investment mandate. Institutional allocators would engage with Elevance Health at the parent-company level through public equities, fixed income, or private credit markets rather than through a direct investment in the PBM subsidiary.
What is CarelonRx's approach to evidence-based formulary design?
CarelonRx emphasizes real-world data and clinical evidence in its coverage decisions. In 2025, the firm published a study analyzing GLP-1 receptor agonists using real-world data to evaluate therapeutic risks and benefits, reflecting its reliance on applied research to guide formulary placement and utilization management.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: